Acanthamoeba Keratitis Clinical Trial
Official title:
Parasitic Ulcer Treatment Trial
The Parasitic Ulcer Treatment Trial (PUTT) is a multi-center, parallel-group, randomized clinical trial. The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis (AK) will improve vision. Patients presenting to all enrollment centers with evidence of acanthamoeba keratitis will be eligible for the trial if there is evidence of ocular inflammation after 4 weeks of anti-amoebic therapy. Those who agree to participate will be randomized to one of two treatment groups: - Group 1: Topical corticosteroid - Group 2: Topical placebo
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02506257 -
Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects
|
Phase 1 | |
| Not yet recruiting |
NCT06332703 -
Acanthamoeba and Artificial Intelligence
|
||
| Enrolling by invitation |
NCT03461978 -
Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures
|
N/A | |
| Recruiting |
NCT02763605 -
Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years
|
N/A | |
| Active, not recruiting |
NCT03484507 -
Parasitic Ulcer Treatment Trial Pilot
|
Phase 2 | |
| Active, not recruiting |
NCT05110001 -
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
|
Phase 3 | |
| Completed |
NCT03274895 -
Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis
|
Phase 3 |